Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis C explained
My review of advice on Hepatitis C is split into section so that people who want information can find it fast without having to read endless babble that is of no help to their specific requirements. The sections of the review are as follows : 1.Who is

Hepatitis C does not slow down HIV recovery
Extract not available.

Natalie Cole Diagnosed with Hepatitis C
Grammy winner and songstress Natalie Cole has been diagnosed with Hepatitis C, according to many ongoing reports last week. Cole's publicist, Lellie Capwell released a statement to the public last Wednesday that the singer may have contracted the liver

UPDATES AND COMMENTARY RSS Feed

Natalie Cole Optimistic About Her Battle with Hepatitis C
Although currently recovering from combination therapy's side effects, the well-respected vocalist Natalie Cole may have conquered the Hepatitis C virus....

Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....

Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...

Vox Sang 1998;74 Suppl 2:143-146

Epidemiology of the hepatitis C virus.

Ebeling F

Finnish Red Cross Blood Transfusion Service, Helsinki, Finland. freja.ebeling@bts.redcross.fi

According to WHO estimations, about 3% of the world population may be infected with the hepatitis C virus. The relative prevalences of subtypes of this virus vary in different geographic areas. The main known routes of transmission are parenteral; intravenous drug abuse, contaminated injection devices and receipt of unscreened blood. Sexual, vertical, household and nosocomial transmissions may occur, but seem to be rare. The risk of screened blood or blood products is now almost eliminated, but unscreened blood is a considerable risk in areas where screening is economically not possible. The future impact of this virus is greatly dependent on the trends in intravenous drug use as well as the possible emergence of increased late morbidity among present asymptomatic carriers during the next decades.

PMID: 9704437, UI: 98370060

table Of Contents

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 25 Jul 2008